# ITT4 Intratesticular Hormonal Milieu in Man (ITT4)

> **NCT01215292** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Washington** · enrollment: 46 (actual)

## Conditions studied

- Healthy Males

## Interventions

- **DRUG:** Acyline
- **DRUG:** Testosterone gel
- **DRUG:** ketoconazole 400
- **DRUG:** Ketoconazole 800
- **DRUG:** Dutasteride
- **DRUG:** Anastrozole
- **DRUG:** Placebo ketoconazole

## Key facts

- **NCT ID:** NCT01215292
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2014-03-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01215292

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01215292, "ITT4 Intratesticular Hormonal Milieu in Man (ITT4)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01215292. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*